Post-covid conditions (‘Long covid’ and other sequelae of covid disease)

Fiona Godlee hosts a discussion on the clinical definition, data, prognosis, and management of long Covid and post-viral sequelae.

4.00 Welcome -Fiona Godlee, editor in chief of The BMJ MC Phil Hammond, physician and journalist for Private Eye 4.05 ‘What is 'long covid'/ post-covid? - George Davey Smith, professor of clinical epidemiology, University of Bristol - Elaine Maxwell  Clinical Adviser at the National Institute for Health Research (NIHR) Dissemination Centre - Jo House, Reader in Environmental Science and Policy at the University of Bristol on patient perspectives 4.25 International experience: What and where are the best data? - Chair: Fiona Godlee, editor in chief of The BMJ - Ben Humberstone, head of health analysis and Life Events and Daniel Ayoubkhani, principal statistician, at the UK’s Office of National Statistics - Simone Benatt, Infectivolgy Department, Papa Giovanni XXIII Hospital, Italy - Maxime Taquet, academic clinical fellow at University of Oxford 5.00 Prognosis, available treatments, and rehabilitation - Chair: Allyson Pollock, professor of public health, Newcastle University) - Melissa Heightman, Integrated respiratory consultant, University College London Hospital - Margaret McCartney, GP, and Richard Byng, GP - Liz Whittaker, senior clinical lecturer in paediatric infectious diseases and immunology at Imperial College London - Rob Barker-Davies, Defence Medical Rehabilitation Centre 5.35 The Future? chair: Fiona Godlee, editor in chief of The BMJ 5.45 Discussion and questions (chair: Phil Hammond) -All panelists 6.15 Close